Kendric Cromer, a 12-year-old boy, is the first person in the world with sickle cell disease to begin a commercially approved gene therapy, offering hope for a cure.
The treatment signals hope for the estimated 20,000 sickle cell patients in the U.S. who qualify, aiming to enable lives they've longed for, like Kendric's new chance at a normal life.
[
add
]
[
|
|
...
]